This is an OxSTAI (Oxford Network for Sustainable and Trustworthy AI in Health and Care) event.

Artificial Intelligence has enormous potential in healthcare, with a vast number of tools already available for use in clinical settings. Despite this, adoption has been slow and evidence for their efficacy remains limited. In this seminar we will hear from two leading experts at the fore front of AI implementation in the clinical context.

Dr Rubeta Matin will focus on the real-world use of skin cancer diagnostic AI in UK care pathways, drawing on evidence from tele-dermatology pilots and CE-marked tools. Her talk will outline observed impacts on accuracy, and workflow, and examine the remaining questions around safety, evaluation, accountability, and whether these systems deliver measurable benefit for patients and the health system.

Dr Alex Novak will focus on AI-assisted image interpretation as the most well-established clinical use case. He will explore the current evidence landscape for clinical AI, and look at some of the recent and current work of Oxford Clinical AI Research (OxCAIR) which aims to address that evidence gap.

Chair: Angeliki Kerasidou

Speaker Bio: Alex Novak is a Consultant in Emergency Medicine and Associate Professor of the Royal College of Emergency Medicine and a Clinical Specialist Advisor at Trinity College, Oxford. His main research interests are based primarily around the use and development of diagnostic technology in acute healthcare settings, in particular the evaluation of Artificial Intelligence-enhanced imaging. He leads the Oxford Clinical Artificial Intelligence Research Group (OxCAIR), a multidisciplinary research group based in Oxford University Hospitals NHS Foundation Trust, which focuses on the evaluation of regulator approved and commercially available digital health technologies, especially AI.

Speaker Bio: Rubeta Matin is a Consultant Dermatologist at Oxford University Hospitals NHS Foundation Trust, Honorary Senior Lecturer at University of Oxford , and a Fellow of the Alan Turing Institute. She holds a number of national leadership roles including Chair of the British Association of Dermatologists Artificial Intelligence (AI) Working Party Group and is specialist member of the MHRA Interim Medical Devices and Software and AI Expert Advisory Groups. Dr Matin is also a member of the WHO Focus Group on AI for Health (FG-AI4H) developing standardised benchmarking of AI-based technologies for health.